SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-001742
Filing Date
2024-12-19
Accepted
2024-12-19 17:22:27
Documents
14
Period of Report
2024-12-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 31294
  Complete submission text file 0001079973-24-001742.txt   255067

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE toi-20241219.xsd EX-101.SCH 3912
3 XBRL DEFINITION FILE toi-20241219_def.xml EX-101.DEF 26804
4 XBRL LABEL FILE toi-20241219_lab.xml EX-101.LAB 37033
5 XBRL PRESENTATION FILE toi-20241219_pre.xml EX-101.PRE 25428
16 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 843562323 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 241564255
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)